Check out our most recent annual report, highlighting our successes and work over the past year.
Feist-Weiller Cancer Center is North Louisiana's only academic cancer center and began as a designated a Center of Excellence in Cancer Research, Treatment and Education in 1993. The Center was named Feist-Weiller Cancer Center (FWCC) following a generous philanthropic gift by Carroll Feist to honor the Feist and Weiller families. Today, FWCC brings cancer research, clinical care, and medical education together as we work toward new and improved models of cancer prevention and treatment.
Feist-Weiller Cancer Center is supported by the partnership between Ochsner LSU Health Shreveport and LSU Health Shreveport. Feist-Weiller's research and education initiatives are backed by the academic mission of LSU Health Shreveport while Ochsner LSU Health Shreveport oversees the delivery of clinical care at FWCC. Together, collaboration between cancer researchers and treating physicians fosters a comprehensive understanding of cancer, increased access to treatments, and opportunities for patients to participate in clinical trials.
Dr. Sarah Thayer, MD, PhD, FACS
Director of Feist-Weiller Cancer Center
INTEGRATE TO ACCELERATE
Among the signature strengths of Feist-Weiller Cancer Center is translational research. In translational cancer research, basic science findings are translated through clinical care into tomorrow's improved therapies. Physicians and scientists take clinical problems from the bedside to the research laboratory where solutions are generated that come back to the bedside. This type of research allows the scientific discoveries to more rapidly become practical applications that can be used in assessment and treatment of cancer patients.
Feist-Weiller Cancer Center is focused on the coordinated growth of clinical and research programs aimed at cancer prevention and control. In 2021, we began reorganizing our cancer research programs to strategically address four critical areas of cancer research:
- Genetics and Cancer Biology
- Viral Oncology and Immunology
- Cancer Preventative Control and Health Care Disparities
- Developmental: Clinical and Translational Oncology/Cancer Therapeutics
MISSION AND VALUES
Feist-Weiller Cancer Center engages in multidisciplinary, translational cancer research, provides patients cutting-edge treatment with access to national cancer clinical trials, and educates both physicians and the community about the prevention, treatment, and the science of cancer.
The Feist-Weiller Cancer Center team is committed to bringing life-saving discoveries about cancer to all of Louisiana and beyond. Collaboration between cancer researchers and treating physicians fosters a more comprehensive understanding of cancer. Feist-Weiller Cancer Center faculty:
- Conduct laboratory research and clinical research to discover better methods of preventing and treating cancer
- Provide adult and pediatric patients with state-of-the-art cancer care, regardless of their ability to pay
- Educate and train Hematology/Oncology Fellows, community physicians, and local residents about the most modern cancer treatments so all patients will receive the best possible cancer care
- Supply Louisiana communities with cancer screenings and education materials for prevention through Partners in Wellness, a unique community cancer screening program
KSLA12 - Overall, the breast cancer death rate dropped 43 percent between 1989 and 2020. However, Black women have a 40 percent higher mortality rate than other ethnic groups then it comes to breast cancer. Dr. Sarah Thayer, Director of the Feist-Weiller Cancer Center at LSUHS shares more about these disparities.
KSLA - Dr. Sarah Thayer, Director of Feist-Weiller Cancer Center at LSUHS talks about the risks, family history, and how to reduce the risk of getting breast cancer during Breast Cancer Awareness Month.
Newswise - Sarah Thayer, MD, PhD, Director of the Feist-Weiller Cancer Center at LSUHS, was elected as a new board member of the Association of American Cancer Institutes during the AACI/CCAF Annual Meeting, October 2-4.
KTAL6 - September is Ovarian Cancer Awareness month and Dr. Richard Mansour, professor of Medicine at LSUHS talked about the deadly disease. “In Louisiana, the numbers are about 270 cases with 190 deaths. About two out of three patients get it, die from it.”